Equillium Files 10-Q for Q1 2025
Ticker: EQ · Form: 10-Q · Filed: May 14, 2025 · CIK: 1746466
| Field | Detail |
|---|---|
| Company | Equillium, INC. (EQ) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceutical, financial-report
TL;DR
Equillium's Q1 2025 10-Q is in. Check Ono and Syngene deal updates.
AI Summary
Equillium, Inc. filed its 10-Q for the period ending March 31, 2025. The company's fiscal year ends on December 31st. Key financial data and business activities are reported, including details related to agreements with Ono Pharmaceutical Co., Ltd. and Syngene International Limited.
Why It Matters
This filing provides investors with an update on Equillium's financial health and operational progress for the first quarter of 2025, including details on significant agreements.
Risk Assessment
Risk Level: medium — The company operates in the pharmaceutical sector, which is inherently high-risk due to R&D, regulatory hurdles, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End (Quarterly financial update)
- 2025-05-14 — Filing Date (Date the report was submitted)
Key Players & Entities
- Equillium, Inc. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250514 (date) — Filing Date
- Ono Pharmaceutical Co., Ltd. (company) — Partner in Asset Purchase Agreement
- Syngene International Limited (company) — Partner in Master Services Agreement
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
Which company is the primary filer of this document?
Equillium, Inc. is the primary filer of this document.
Are there any specific agreements mentioned in the filing details?
Yes, the filing details mention an Asset Purchase Agreement with Ono Pharmaceutical Co., Ltd. and a Master Services Agreement with Syngene International Limited.
What is Equillium, Inc.'s Standard Industrial Classification code?
Equillium, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Equillium, Inc. (EQ).